Protagonist Therapeutics raises $22m equity financing from BVF Partners
Protagonist Therapeutics, a US biopharma company, focused on discovering and development of novel peptide-based drugs for patients with significant unmet
Continue readingCoverage of Global Pharma Industry News
Protagonist Therapeutics, a US biopharma company, focused on discovering and development of novel peptide-based drugs for patients with significant unmet
Continue readingSpanish pharma company PharmaMar’s lurbinectedin has secured orphan drug designation from the US Food and Drug Administration (FDA) for the
Continue readingPhase 3 trial for apomorphine infusion : British pharma company Britannia Pharmaceuticals said that its APO-go/MOVAPO (apomorphine) subcutaneous infusion has
Continue reading